demyelin axon defender determine progress neurology disable patient multiple sclerosis m cell revid within central nervous system cn active particle develop progress subset control autoimmune disease howe individual contribute well understood astrocyt abound cell type highly density environment cue italic detriment protect outcome experiment encephalomyel eae induce transfer mouse express signal defect dominantneg interferon gamma inÎ³ receptor determine influence inflamed astrocyt active inhibit rcid onset init symptom blood brain barrier bbb inter composite act inflammatory response nevertheless increase peak absence correct sustain clinic follow diminish remains mortal active gray matter demons critic role neuroprotect assoc escale infiltr leukocyt alter decrease il data india play limit depend upon neuroprotect pathway media engage 